We have also established that CAMK2B exerts its influence through the Ras/Raf/MEK/ERK signaling pathway, thereby presenting novel therapeutic targets and avenues for future research in the diagnosis and treatment of glioma. The gene discussed is RAF1; the disease is central nervous system cancer.